Publications by authors named "Edwin Mak"

Claim this Profile
S
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
Daryl J Wile, Pankaj A Agarwal, Michael Schulzer, Edwin Mak, Katherine Dinelle

Lancet Neurol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[11C]PBR28 PET imaging is sensitive to neuroinflammation in the aged rat.
Matthew D Walker, Katherine Dinelle, Rick Kornelsen, Nathan V Lee, Qing Miao, Edwin Mak

J Cereb Blood Flow Metab· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The nature of progression in Parkinson's disease: an application of non-linear, multivariate, longitudinal random effects modelling.
Lisa Kuramoto, Jacquelyn Cragg, Ramachandiran Nandhagopal, Edwin Mak, Vesna Sossi

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does this patient with liver disease have cirrhosis?
Jacob A Udell, Charlie S Wang, Jill Tinmouth, J Mark FitzGerald, Najib T Ayas, Edwin Mak

JAMA· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease.
Ramachandiran Nandhagopal, Lisa Kuramoto, Michael Schulzer, Edwin Mak, Jacqueline Cragg

Brain· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Raúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, Jacquelyn Cragg, Nandhagopal Ramachandiran, Edwin Mak

Ann Neurol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levodopa and pramipexole effects on presynaptic dopamine PET markers and estimated dopamine release.
Vesna Sossi, Katherine Dinelle, Michael Schulzer, Edwin Mak, Doris J Doudet

Eur J Nucl Med Mol Imaging· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of expectation on placebo-induced dopamine release in Parkinson disease.
Sarah C Lidstone, Michael Schulzer, Katherine Dinelle, Edwin Mak, Vesna Sossi

Arch Gen Psychiatry· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trials of neuroprotective therapies for Parkinson's disease: problems and limitations.
Raúl de la Fuente-Fernández, Michael Schulzer, Edwin Mak, Vesna Sossi

Parkinsonism Relat Disord· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to heat pain stimulation in idiopathic Parkinson's disease.
R Nandhagopal, Andre R Troiano, Edwin Mak, Michael Schulzer, Mary Catherine Bushnell

Pain Med· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function.
André R Troiano, Michael Schulzer, Raul de la Fuente-Fernandez, Edwin Mak, Jess McKenzie

Synapse· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proportion of injured drivers presenting to a tertiary care emergency department who engage in future impaired driving activities.
Roy Purssell, Douglas Brown, Jeffery R Brubacher, Jean Wilson, Ming Fang, Edwin Mak

Traffic Inj Prev· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis.
Warren J Davidson, Del Dorscheid, Roger Spragg, Michael Schulzer, Edwin Mak

Crit Care· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
John R Adams, Hinke van Netten, Michael Schulzer, Edwin Mak, Jessamyn Mckenzie

Brain· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does this dyspneic patient in the emergency department have congestive heart failure?
Charlie S Wang, J Mark FitzGerald, Michael Schulzer, Edwin Mak, Najib T Ayas

JAMA· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical student selection: choice of a semi-structured panel interview or an unstructured one-on-one interview.
Carol Ann Courneya, Kristin Wright, Vera Frinton, Edwin Mak, Michael Schulzer

Med Teach· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-gamma1b therapy in idiopathic pulmonary fibrosis: a metaanalysis.
Ednan K Bajwa, Najib T Ayas, Michael Schulzer, Edwin Mak, Jay H Ryu

Chest· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment for the progression of Parkinson's disease.
Donald Calne, Michael Schulzer, Edwin Mak, A Jon Stoessl

Lancet Neurol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis.
Chong S Lee, Michael Schulzer, Raúl de la Fuente-Fernández, Edwin Mak, Lisa Kuramoto

Arch Neurol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clustering of Parkinson disease: shared cause or coincidence?
Ajit Kumar, Susan M Calne, Michael Schulzer, Edwin Mak, Zbigniew Wszolek

Arch Neurol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
Raúl de la Fuente-Fernández, Michael Schulzer, Edwin Mak, Donald B Calne, A Jon Stoessl

Brain· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The psychometric properties of the Parkinson's Impact Scale (PIMS) as a measure of quality of life in Parkinson's disease.
Michael Schulzer, Edwin Mak, Susan M Calne

Parkinsonism Relat Disord· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validating a quality-of-life scale in caregivers of patients with Parkinson's disease: Parkinson's Impact Scale (PIMS).
Susan M Calne, Edwin Mak, Jeanne Hall, Marie-Jose Fortin, Pamela King

Adv Neurol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis